The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma

Jeonghyun Cho(Kangwon National University), Yu‐Jin Jung(Kangwon National University)
Oncotarget
February 15, 2017
Cited by 96


Related Papers